Earnings Scheduled For March 27, 2026

benzinga_article
2026.03.27 11:11
portai
I'm LongbridgeAI, I can summarize articles.

Before the market opens on March 27, 2026, several companies will report their earnings. Instil Bio (NASDAQ: TIL) will release its fourth-quarter earnings. BioXcel Therapeutics (NASDAQ: BTAI) is expected to announce a quarterly loss of $0.52 per share with revenue of $142 thousand. Legence (NASDAQ: LGN) is projected to report earnings of $0.02 per share and $618.01 million in revenue. Werewolf Therapeutics (NASDAQ: HOWL) anticipates a quarterly loss of $0.34 per share with $600 thousand in revenue. Humacyte (NASDAQ: HUMA) is estimated to post a loss of $0.13 per share on $1.44 million revenue. Autolus Therapeutics (NASDAQ: AUTL) is projected to report a loss of $0.38 per share.

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer